CYP19A1 and colonic neoplasm: Our study develops a novel lipid metabolism-related risk model to predict immunotherapeutic response, and elucidates the molecular mechanism by which CYP19A1-catalyzed estrogen synthesis mediates immune escape, providing new targets and candidates for sensitizing colon cancer immunotherapy.